Investigation of optimum hemoglobin levels in older patients with chronic kidney disease

被引:6
|
作者
Kara, Osman [1 ]
Soysal, Pinar [2 ]
Kiskac, Muharrem [3 ]
Smith, Lee [4 ]
Karismaz, Abdulkadir [5 ]
Kazancioglu, Rumeyza [6 ]
机构
[1] Atasehir Medicana Int Hlth Grp, Dept Hematol, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Fac Med, Dept Geriatr Med, Istanbul, Turkey
[3] Bezmialem Vakif Univ, Fac Med, Dept Internal Med, Istanbul, Turkey
[4] Anglia Ruskin Univ, Ctr Hlth Performance & Wellbeing, Cambridge, England
[5] Istanbul Training & Res Hosp, Clin Hematol, Istanbul, Turkey
[6] Bezmialem Vakif Univ, Fac Med, Dept Nephrol, Istanbul, Turkey
关键词
Anemia; Chronic kidney disease; Hemoglobin; Elderly; IRON-DEFICIENCY; ANEMIA; PREVALENCE; MANAGEMENT;
D O I
10.1007/s40520-022-02246-1
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Aim The aim of the present study is to determine target hemoglobin (Hgb) values in older females and males with chronic kidney disease (CKD) according to best performance in mood, gait and balance, muscle strength and activities of daily living, which are important parameters of geriatric assessment. Method Patients' age, gender, education level, and comorbidities were recorded. All the participants underwent comprehensive geriatric assessment (CGA) including Basic and Instrumental Activities of Daily Living for functional evaluation, Tinetti Performance-Oriented Assessment of Mobility and Timed Up and Go Test for fall risk, and hand grip strength for muscle strength. Hgb levels and kidney functions were analyzed on the same day as CGA measurements. Receiver Operating Characteristic (ROC) analysis was used to detect the optimum level of Hgb according to the best performance of CGA parameters. Results 622 elderly CKD patients (69.3% female, 55.7% with anemia) were included. After adjustment for confounders, those with anemia had dynapenia (OR 1.60), high risk of falls (OR 1.60), and decreased functional capacity (OR 1.83) among females and those with anemia had dynapenia (OR 4.31), a high risk of falling (OR 2.42) and decreased functional capacity (OR 2.94) among males. The optimum value of Hgb level is 11.8-12.1 in females and 12.6-12.8 in males according to ROC analysis. Conclusion Anemia is associated with dynapenia, high risk of falls, and decreased functional capacity in older CKD patients regardless of genericity. To prevent these negative outcomes, Hgb should be kept in the range of 11.8-12.1 in older females with CKD and 12.6-12.8 in older males with CKD.
引用
收藏
页码:3055 / 3062
页数:8
相关论文
共 50 条
  • [31] Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients
    Hirakata, Hideki
    Tsubakihara, Yoshiharu
    Gejyo, Fumitake
    Nishi, Shinichi
    Iino, Yasuhiko
    Watanabe, Yuzou
    Suzuki, Masashi
    Saito, Akira
    Akiba, Takashi
    Inaguma, Daijo
    Fukuhara, Shunichi
    Morita, Satoshi
    Hiroe, Michiaki
    Hada, Yoshiyuki
    Suzuki, Makoto
    Akaishi, Makoto
    Aonuma, Kazutaka
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (01) : 28 - 35
  • [32] The Epidemic Challenge of Chronic Kidney Disease in Older Patients
    Abdelhafiz, Ahmed H.
    Tan, Evelyn
    El Nahas, Meguid
    POSTGRADUATE MEDICINE, 2008, 120 (04) : 87 - 94
  • [33] Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa
    Lefebvre, Patrick
    Vekeman, Francis
    Sarokhan, Brenda
    Enny, Christopher
    Provenzano, Robert
    Cremieux, Pierre-Yves
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (10) : 1929 - 1937
  • [34] Association between hemoglobin and chronic kidney disease progression: a secondary analysis of a prospective cohort study in Japanese patients
    Pan, Wushan
    Han, Yong
    Hu, Haofei
    He, Yongcheng
    BMC NEPHROLOGY, 2022, 23 (01)
  • [35] Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated
    Wong, Michelle M. Y.
    Tu, Charlotte
    Li, Yun
    Perlman, Rachel L.
    Pecoits-Filho, Roberto
    Lopes, Antonio A.
    Narita, Ichiei
    Reichel, Helmut
    Port, Friedrich K.
    Sukul, Nidhi
    Stengel, Benedicte
    Robinson, Bruce M.
    Massy, Ziad A.
    Pisoni, Ronald L.
    CLINICAL KIDNEY JOURNAL, 2020, 13 (04) : 613 - 624
  • [36] Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study
    Yamamoto, Tae
    Miyazaki, Mariko
    Nakayama, Masaaki
    Yamada, Gen
    Matsushima, Masato
    Sato, Mistuhiro
    Sato, Toshinobu
    Taguma, Yoshio
    Sato, Hiroshi
    Ito, Sadayoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (04) : 595 - 602
  • [37] Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease
    Yilmaz, Mahmut I.
    Sonmez, Alper
    Saglam, Mutlu
    Gulec, Mahir
    Kilic, Selim
    Eyileten, Tayfun
    Caglar, Kayser
    Oguz, Yusuf
    Vural, Abdulgaffar
    Yenicesu, Mujdat
    Zoccali, Carmine
    KIDNEY INTERNATIONAL, 2009, 75 (12) : 1316 - 1321
  • [38] Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study
    Tae Yamamoto
    Mariko Miyazaki
    Masaaki Nakayama
    Gen Yamada
    Masato Matsushima
    Mistuhiro Sato
    Toshinobu Sato
    Yoshio Taguma
    Hiroshi Sato
    Sadayoshi Ito
    Clinical and Experimental Nephrology, 2016, 20 : 595 - 602
  • [39] Exploring the Relationships between Hemoglobin, the Endothelium and Vascular Health in Patients with Chronic Kidney Disease
    Weber, Catherine
    Sigrist, Mhairi
    Romann, Alexandra
    Whalen, Beth A.
    Levin, Adeera
    NEPHRON EXTRA, 2011, 1 (01): : 190 - 200
  • [40] Ferric Citrate in Patients With Chronic Kidney Disease
    Block, Geoffrey A.
    SEMINARS IN NEPHROLOGY, 2016, 36 (02) : 130 - 135